[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-001", "question": "A 14-year-old boy with juvenile idiopathic arthritis presents with acute onset of fever, rash, and joint swelling after starting etanercept therapy. Laboratory findings include elevated ferritin, pancytopenia, and hypertriglyceridemia. What is the most appropriate next step in management?", "options": ["Discontinue etanercept and initiate high-dose corticosteroids", "Administer intravenous immunoglobulin", "Start rituximab infusion", "Perform bone marrow biopsy immediately", "Initiate broad-spectrum antibiotics"], "answer": "A", "answer_index": 0, "explanation": "This presentation is consistent with macrophage activation syndrome (MAS), a life-threatening complication in rheumatic diseases like juvenile idiopathic arthritis, often triggered by biologic agents such as etanercept. Discontinuing the offending agent and starting high-dose corticosteroids is the initial management to control the cytokine storm. Bone marrow biopsy may confirm hemophagocytosis but is not the immediate next step, and antibiotics are inappropriate without evidence of infection.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a classic presentation of Macrophage Activation Syndrome (MAS), a life-threatening complication of Juvenile Idiopathic Arthritis (JIA). The key features—fever, rash, pancytopenia, elevated ferritin, and hypertriglyceridemia—satisfy the diagnostic criteria for MAS (secondary HLH). The most appropriate immediate management is the initiation of high-dose corticosteroids (e.g., pulse methylprednisolone) to suppress the cytokine storm. Discontinuing the current biologic (etanercept) is also standard practice, as it may be a trigger or ineffective, and immunosuppression needs to be modulated. While Option E (antibiotics) is clinically relevant because sepsis is a top differential in a febrile, pancytopenic patient, the specific inclusion of hypertriglyceridemia and high ferritin points definitively to MAS for the purpose of the examination. Option D (biopsy) is useful for diagnosis (demonstrating hemophagocytosis) but treatment should not be delayed for this procedure. Therefore, Option A is the unique best answer representing the specific therapy for the diagnosed condition.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a classic presentation of Macrophage Activation Syndrome (MAS), a life-threatening complication of Juvenile Idiopathic Arthritis (JIA). The key features—fever, rash, pancytopenia, elevated ferritin, and hypertriglyceridemia—satisfy the diagnostic criteria for MAS (secondary HLH). The most appropriate immediate management is the initiation of high-dose corticosteroids (e.g., pulse methylprednisolone) to suppress the cytokine storm. Discontinuing the current biologic (etanercept) is also standard practice, as it may be a trigger or ineffective, and immunosuppression needs to be modulated. While Option E (antibiotics) is clinically relevant because sepsis is a top differential in a febrile, pancytopenic patient, the specific inclusion of hypertriglyceridemia and high ferritin points definitively to MAS for the purpose of the examination. Option D (biopsy) is useful for diagnosis (demonstrating hemophagocytosis) but treatment should not be delayed for this procedure. Therefore, Option A is the unique best answer representing the specific therapy for the diagnosed condition.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-002", "question": "A 65-year-old man with hypertrophic cardiomyopathy develops sudden syncope during exercise. Echocardiography shows left ventricular outflow tract obstruction with a gradient of 80 mmHg. Despite beta-blocker therapy, symptoms persist. What is the most definitive management option?", "options": ["Surgical septal myectomy", "Alcohol septal ablation", "Implantable cardioverter-defibrillator placement", "Dual-chamber pacing", "Verapamil initiation"], "answer": "A", "answer_index": 0, "explanation": "Surgical septal myectomy is the gold standard for symptomatic hypertrophic cardiomyopathy with severe outflow tract obstruction refractory to medical therapy, offering superior long-term outcomes in experienced centers. Alcohol septal ablation is an alternative but carries risks like heart block and is less effective in younger patients. ICD placement addresses arrhythmic risk but not the obstruction itself.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with symptomatic hypertrophic obstructive cardiomyopathy (HOCM) characterized by a severe LVOT gradient (80 mmHg) and syncope, which is refractory to first-line medical therapy (beta-blockers). The question asks for the 'most definitive management option.' Surgical septal myectomy (Option A) is the recognized gold standard (definitive treatment) for drug-refractory HOCM in patients who are surgical candidates, providing structural correction of the obstruction. While Alcohol Septal Ablation (Option B) is an alternative, it is generally reserved for patients at high surgical risk and is associated with higher residual gradients and pacemaker requirements. Option C (ICD) is indicated for SCD prevention given the history of exertional syncope, but it does not treat the underlying hemodynamic obstruction or the symptoms caused by it, and thus is not the 'definitive management' of the disease process described. The stem's emphasis on the gradient and medical failure points specifically to Septal Reduction Therapy, with surgery being superior to ablation.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with symptomatic hypertrophic obstructive cardiomyopathy (HOCM) characterized by a severe LVOT gradient (80 mmHg) and syncope, which is refractory to first-line medical therapy (beta-blockers). The question asks for the 'most definitive management option.' Surgical septal myectomy (Option A) is the recognized gold standard (definitive treatment) for drug-refractory HOCM in patients who are surgical candidates, providing structural correction of the obstruction. While Alcohol Septal Ablation (Option B) is an alternative, it is generally reserved for patients at high surgical risk and is associated with higher residual gradients and pacemaker requirements. Option C (ICD) is indicated for SCD prevention given the history of exertional syncope, but it does not treat the underlying hemodynamic obstruction or the symptoms caused by it, and thus is not the 'definitive management' of the disease process described. The stem's emphasis on the gradient and medical failure points specifically to Septal Reduction Therapy, with surgery being superior to ablation.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-003", "question": "A term neonate develops respiratory distress and hypotension shortly after birth. Physical exam reveals hepatomegaly and poor perfusion. Echocardiogram shows dilated cardiomyopathy. Maternal history includes untreated systemic lupus erythematosus. What is the underlying mechanism?", "options": ["Transplacental passage of anti-Ro/SSA antibodies causing atrioventricular block", "Congenital viral infection leading to myocarditis", "Inborn error of metabolism affecting cardiac function", "Asphyxia-induced hypoxic cardiomyopathy", "Genetic mutation in sarcomeric proteins"], "answer": "A", "answer_index": 0, "explanation": "Neonatal lupus from maternal anti-Ro/SSA antibodies can cause complete heart block and cardiomyopathy, leading to heart failure in the newborn. This is distinct from viral myocarditis, which typically presents later and lacks the maternal autoimmune history. Metabolic or genetic causes are less likely without additional syndromic features.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a neonate with signs of heart failure (hepatomegaly, hypotension, poor perfusion) and dilated cardiomyopathy. The critical discriminating feature is the maternal history of untreated Systemic Lupus Erythematosus (SLE). This clinical picture is characteristic of Neonatal Lupus Erythematosus (NLE). The pathophysiology involves the transplacental passage of maternal anti-Ro/SSA (or anti-La/SSB) antibodies, which target the fetal conduction system and myocardium. This leads to congenital heart block (CHB) and/or cardiomyopathy (often with endocardial fibroelastosis). Option A correctly identifies the specific immunologic mechanism (transplacental antibodies) and the hallmark manifestation (AV block) associated with the maternal history. While the cardiomyopathy can be a direct result of inflammation or secondary to the bradycardia from the block, Option A is the only choice that links the maternal condition to the fetal pathology. Options B, C, D, and E represent other causes of neonatal cardiomyopathy but fail to account for the specific maternal risk factor provided.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a neonate with signs of heart failure (hepatomegaly, hypotension, poor perfusion) and dilated cardiomyopathy. The critical discriminating feature is the maternal history of untreated Systemic Lupus Erythematosus (SLE). This clinical picture is characteristic of Neonatal Lupus Erythematosus (NLE). The pathophysiology involves the transplacental passage of maternal anti-Ro/SSA (or anti-La/SSB) antibodies, which target the fetal conduction system and myocardium. This leads to congenital heart block (CHB) and/or cardiomyopathy (often with endocardial fibroelastosis). Option A correctly identifies the specific immunologic mechanism (transplacental antibodies) and the hallmark manifestation (AV block) associated with the maternal history. While the cardiomyopathy can be a direct result of inflammation or secondary to the bradycardia from the block, Option A is the only choice that links the maternal condition to the fetal pathology. Options B, C, D, and E represent other causes of neonatal cardiomyopathy but fail to account for the specific maternal risk factor provided.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-004", "question": "A 28-year-old woman at 32 weeks gestation presents with severe preeclampsia and acute dyspnea. Echocardiography reveals peripartum cardiomyopathy with ejection fraction of 30%. What is the most critical intervention to improve maternal outcomes?", "options": ["Immediate delivery via cesarean section", "Initiate bromocriptine to suppress prolactin", "Administer intravenous furosemide and vasodilators", "Start anticoagulation with low-molecular-weight heparin", "Perform urgent cardiac transplantation evaluation"], "answer": "B", "answer_index": 1, "explanation": "Bromocriptine inhibits prolactin, which is implicated in the pathogenesis of peripartum cardiomyopathy, and has shown benefit in improving left ventricular function when added to standard heart failure therapy. Immediate delivery may be necessary for preeclampsia but does not directly address cardiomyopathy. Diuretics and vasodilators manage symptoms but are not disease-modifying in this context.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with severe preeclampsia and acute decompensated heart failure (PPCM) at 32 weeks. The standard of care for severe preeclampsia with maternal end-organ dysfunction (pulmonary edema/heart failure) is maternal stabilization followed by delivery. Therefore, Option A (Delivery) is the definitive treatment, and Option C (Diuretics/Vasodilators) is the immediate life-saving stabilization step. Option B (Bromocriptine) is an adjunctive, investigational therapy (Class IIb or IIa in some guidelines) used to prevent further prolactin-mediated damage, but it is never the 'most critical' intervention superseding delivery or acute hemodynamic management. Prioritizing bromocriptine over delivery in a patient with severe preeclampsia and acute dyspnea is medically inaccurate and potentially dangerous. The item is miskeyed; Option A is the most defensible 'best' answer for maternal outcome among the choices, as delivery resolves the preeclampsia and hemodynamic load.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with severe preeclampsia and acute decompensated heart failure (PPCM) at 32 weeks. The standard of care for severe preeclampsia with maternal end-organ dysfunction (pulmonary edema/heart failure) is maternal stabilization followed by delivery. Therefore, Option A (Delivery) is the definitive treatment, and Option C (Diuretics/Vasodilators) is the immediate life-saving stabilization step. Option B (Bromocriptine) is an adjunctive, investigational therapy (Class IIb or IIa in some guidelines) used to prevent further prolactin-mediated damage, but it is never the 'most critical' intervention superseding delivery or acute hemodynamic management. Prioritizing bromocriptine over delivery in a patient with severe preeclampsia and acute dyspnea is medically inaccurate and potentially dangerous. The item is miskeyed; Option A is the most defensible 'best' answer for maternal outcome among the choices, as delivery resolves the preeclampsia and hemodynamic load.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-005", "question": "In the ICU, a 55-year-old patient with septic shock on vasopressors develops acute kidney injury and metabolic acidosis. Despite fluid resuscitation, oliguria persists. Continuous renal replacement therapy is initiated. What is the most appropriate modality to optimize hemodynamic stability?", "options": ["Continuous venovenous hemodiafiltration with citrate anticoagulation", "Intermittent hemodialysis with bicarbonate buffer", "Sustained low-efficiency dialysis", "Peritoneal dialysis", "Continuous venovenous hemofiltration alone"], "answer": "A", "answer_index": 0, "explanation": "Continuous venovenous hemodiafiltration (CVVHDF) provides both convective and diffusive clearance, making it ideal for septic shock with acidosis, and citrate anticoagulation minimizes clotting while providing regional effects. Intermittent hemodialysis can cause hemodynamic instability in critically ill patients. Peritoneal dialysis is less efficient for rapid toxin removal in this setting.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with septic shock and AKI requiring renal replacement therapy. The keyed answer, Option A (CVVHDF with citrate anticoagulation), correctly identifies the standard of care (KDIGO guidelines) for this patient population, prioritizing filter patency and clearance. However, the question specifically asks for the modality to 'optimize hemodynamic stability.' While CRRT (Options A and E) is widely accepted as superior to Intermittent Hemodialysis (Option B) for hemodynamic stability, there is no intrinsic hemodynamic difference between CVVHDF (A) and CVVH (E). Both are continuous therapies with comparable hemodynamic profiles. The clinical preference for A over E is driven by clearance efficiency (combining diffusion and convection) and anticoagulation benefits, not stability. Therefore, the stem's specific criterion ('optimize hemodynamic stability') fails to uniquely discriminate the key from Option E. Additionally, the phrase 'Continuous renal replacement therapy is initiated' creates a logical timeline contradiction or redundancy, as it implies the modality decision is already made, logically excluding Options B, C, and D. This leaves a choice between A and E, which are tied regarding the stated criterion. Thus, the item is logically flawed as the question asked does not align with the distinguishing features of the correct answer.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with septic shock and AKI requiring renal replacement therapy. The keyed answer, Option A (CVVHDF with citrate anticoagulation), correctly identifies the standard of care (KDIGO guidelines) for this patient population, prioritizing filter patency and clearance. However, the question specifically asks for the modality to 'optimize hemodynamic stability.' While CRRT (Options A and E) is widely accepted as superior to Intermittent Hemodialysis (Option B) for hemodynamic stability, there is no intrinsic hemodynamic difference between CVVHDF (A) and CVVH (E). Both are continuous therapies with comparable hemodynamic profiles. The clinical preference for A over E is driven by clearance efficiency (combining diffusion and convection) and anticoagulation benefits, not stability. Therefore, the stem's specific criterion ('optimize hemodynamic stability') fails to uniquely discriminate the key from Option E. Additionally, the phrase 'Continuous renal replacement therapy is initiated' creates a logical timeline contradiction or redundancy, as it implies the modality decision is already made, logically excluding Options B, C, and D. This leaves a choice between A and E, which are tied regarding the stated criterion. Thus, the item is logically flawed as the question asked does not align with the distinguishing features of the correct answer.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-006", "question": "A 45-year-old woman with rheumatoid arthritis on methotrexate develops progressive dyspnea and dry cough. High-resolution CT shows subpleural reticular opacities and traction bronchiectasis. Pulmonary function tests reveal restrictive pattern. What is the most likely diagnosis?", "options": ["Methotrexate-induced interstitial lung disease", "Rheumatoid arthritis-associated usual interstitial pneumonia", "Hypersensitivity pneumonitis from environmental exposure", "Non-specific interstitial pneumonia", "Cryptogenic organizing pneumonia"], "answer": "B", "answer_index": 1, "explanation": "Rheumatoid arthritis can cause interstitial lung disease with a usual interstitial pneumonia pattern, which is more common than methotrexate toxicity in long-term users. Methotrexate-induced ILD typically presents acutely and improves upon discontinuation, unlike this progressive course. Hypersensitivity pneumonitis would show upper lobe predominance and different triggers.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict on keyed answer: Correct best. The vignette describes a patient with Rheumatoid Arthritis (RA) presenting with progressive dyspnea and HRCT findings of subpleural reticular opacities and traction bronchiectasis. These imaging features are characteristic of a Usual Interstitial Pneumonia (UIP) pattern. Among Connective Tissue Diseases (CTDs), RA is uniquely associated with the UIP pattern as the most common presentation (unlike SSc or myositis, which favor NSIP). Methotrexate-induced lung injury typically presents as a subacute hypersensitivity pneumonitis (ground-glass opacities, fever) rather than chronic fibrosis with traction bronchiectasis. While distinguishing fibrotic NSIP from UIP can be difficult without histology or honeycombing, the specific mention of subpleural reticular changes without ground-glass opacities strongly favors UIP. Therefore, RA-associated UIP is the most likely diagnosis. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict on keyed answer: Correct best. The vignette describes a patient with Rheumatoid Arthritis (RA) presenting with progressive dyspnea and HRCT findings of subpleural reticular opacities and traction bronchiectasis. These imaging features are characteristic of a Usual Interstitial Pneumonia (UIP) pattern. Among Connective Tissue Diseases (CTDs), RA is uniquely associated with the UIP pattern as the most common presentation (unlike SSc or myositis, which favor NSIP). Methotrexate-induced lung injury typically presents as a subacute hypersensitivity pneumonitis (ground-glass opacities, fever) rather than chronic fibrosis with traction bronchiectasis. While distinguishing fibrotic NSIP from UIP can be difficult without histology or honeycombing, the specific mention of subpleural reticular changes without ground-glass opacities strongly favors UIP. Therefore, RA-associated UIP is the most likely diagnosis. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-007", "question": "A 2-year-old child with hypoplastic left heart syndrome post-Norwood procedure presents with cyanosis and metabolic acidosis. Echocardiography shows right ventricular dysfunction and tricuspid regurgitation. What is the most appropriate pharmacologic intervention?", "options": ["Milrinone infusion for inotropic support", "Prostaglandin E1 to maintain ductal patency", "Sildenafil for pulmonary hypertension", "Digoxin for rate control", "Epinephrine bolus for hypotension"], "answer": "A", "answer_index": 0, "explanation": "Milrinone provides inotropic support and pulmonary vasodilation, crucial for right ventricular failure in single-ventricle physiology after Norwood. Prostaglandin E1 is used preoperatively but not post-Norwood. Sildenafil targets pulmonary hypertension but lacks the inotropic effect needed here.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid)\\nVerdict on keyed answer: Correct best\\n\\nThe item presents a child with Hypoplastic Left Heart Syndrome (HLHS) and single-ventricle physiology (systemic RV) exhibiting acute decompensation (acidosis, RV dysfunction, TR). The pathophysiology demands an agent that improves contractility (inotropy) and reduces afterload (vasodilation) to support the failing systemic RV. Milrinone (A) is the classic 'inodilator' of choice for this scenario. \\n\\nLogical/Medical critique: The primary flaw is the timeline. A 2-year-old with HLHS is typically post-Glenn or post-Fontan (Stage 2 or 3), not merely 'post-Norwood' (Stage 1, usually neonatal). A 2-year-old relying solely on a Norwood shunt would have severe cyanosis and pulmonary vascular issues incompatible with typical survival. However, ignoring the age/stage discrepancy and focusing on the physiology of 'systemic RV failure,' Milrinone is the only appropriate choice. PGE1 (B) is useless post-Norwood (ductus is removed). Sildenafil (C) lacks necessary inotropy. Epinephrine (E) increases afterload, potentially worsening TR. Despite the clinical realism issue regarding the patient's age, the correct answer is uniquely defensible based on the described hemodynamics.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid)\nVerdict on keyed answer: Correct best\n\nThe item presents a child with Hypoplastic Left Heart Syndrome (HLHS) and single-ventricle physiology (systemic RV) exhibiting acute decompensation (acidosis, RV dysfunction, TR). The pathophysiology demands an agent that improves contractility (inotropy) and reduces afterload (vasodilation) to support the failing systemic RV. Milrinone (A) is the classic 'inodilator' of choice for this scenario. \n\nLogical/Medical critique: The primary flaw is the timeline. A 2-year-old with HLHS is typically post-Glenn or post-Fontan (Stage 2 or 3), not merely 'post-Norwood' (Stage 1, usually neonatal). A 2-year-old relying solely on a Norwood shunt would have severe cyanosis and pulmonary vascular issues incompatible with typical survival. However, ignoring the age/stage discrepancy and focusing on the physiology of 'systemic RV failure,' Milrinone is the only appropriate choice. PGE1 (B) is useless post-Norwood (ductus is removed). Sildenafil (C) lacks necessary inotropy. Epinephrine (E) increases afterload, potentially worsening TR. Despite the clinical realism issue regarding the patient's age, the correct answer is uniquely defensible based on the described hemodynamics.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-008", "question": "A 70-year-old man with atrial fibrillation on anticoagulation develops acute chest pain and hypotension. Coronary angiography shows no obstructive disease, but left ventriculography reveals apical ballooning. What is the underlying pathophysiology?", "options": ["Catecholamine surge leading to transient myocardial stunning", "Spontaneous coronary artery dissection", "Myocarditis from viral infection", "Embolic occlusion of distal coronaries", "Vasospasm induced by ergonovine"], "answer": "A", "answer_index": 0, "explanation": "Takotsubo cardiomyopathy involves catecholamine-mediated myocardial stunning, mimicking acute coronary syndrome without angiographic abnormalities. Dissection would show vessel irregularities on angiography. Myocarditis typically presents with inflammatory markers and different ventricular patterns.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a classic presentation of Takotsubo cardiomyopathy (stress cardiomyopathy), characterized by acute chest pain, hypotension, absence of obstructive coronary artery disease on angiography, and the pathognomonic finding of left ventricular apical ballooning. The underlying pathophysiology is widely accepted to be a catecholamine surge resulting in transient myocardial stunning and microvascular dysfunction. Option A correctly identifies this mechanism. Option B (SCAD) and D (Embolism) would typically present with angiographic evidence of vessel pathology (dissection plane or abrupt cutoff), which is explicitly absent ('no obstructive disease'). Option C (Myocarditis) lacks a viral prodrome and typically presents with global or patchy dysfunction rather than the specific apical ballooning pattern. Option E refers to a provocation test for vasospasm, which is a different entity. The item is medically accurate and logically sound with a unique best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a classic presentation of Takotsubo cardiomyopathy (stress cardiomyopathy), characterized by acute chest pain, hypotension, absence of obstructive coronary artery disease on angiography, and the pathognomonic finding of left ventricular apical ballooning. The underlying pathophysiology is widely accepted to be a catecholamine surge resulting in transient myocardial stunning and microvascular dysfunction. Option A correctly identifies this mechanism. Option B (SCAD) and D (Embolism) would typically present with angiographic evidence of vessel pathology (dissection plane or abrupt cutoff), which is explicitly absent ('no obstructive disease'). Option C (Myocarditis) lacks a viral prodrome and typically presents with global or patchy dysfunction rather than the specific apical ballooning pattern. Option E refers to a provocation test for vasospasm, which is a different entity. The item is medically accurate and logically sound with a unique best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-009", "question": "A 35-year-old pregnant woman at 28 weeks with antiphospholipid syndrome develops thrombocytopenia and elevated liver enzymes. Fetal monitoring shows growth restriction. What is the most appropriate management strategy?", "options": ["Low-dose aspirin and low-molecular-weight heparin continuation with close monitoring", "Immediate delivery to prevent maternal deterioration", "Plasmapheresis for antibody removal", "Intravenous immunoglobulin infusion", "Switch to unfractionated heparin"], "answer": "A", "answer_index": 0, "explanation": "In antiphospholipid syndrome during pregnancy, continuing low-dose aspirin and LMWH is standard to manage thrombotic risks and prevent complications like HELLP-like syndrome, with vigilant monitoring. Immediate delivery is premature at 28 weeks without severe features. IVIG is not first-line and reserved for refractory cases.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Miskeyed (K). Verdict: The keyed answer (A) is medically incorrect; Option B is the most defensible strategy, though imperfect. \\n\\nKey stem clues: 28 weeks gestation, history of APS, *new onset* thrombocytopenia, elevated liver enzymes, and fetal growth restriction (IUGR). \\n\\nMedical Reasoning: The triad of hemolysis (implied by dropping platelets/APS context), elevated liver enzymes, and low platelets (HELLP syndrome), or preeclampsia with severe features, is the most likely diagnosis. According to ACOG and international guidelines, thrombocytopenia and liver dysfunction are *severe features* of preeclampsia. The standard of care for HELLP/severe preeclampsia at 28 weeks is delivery (Option B), typically after a 48-hour course of corticosteroids for fetal lung maturity. \\n\\nLogical/Medical Issue: The provided rationale falsely claims the patient is \\\"without severe features,\\\" directly contradicting the clinical findings in the stem. Option A (continuation of pregnancy with just aspirin/heparin) is dangerous expectant management for a patient with HELLP/severe preeclampsia and IUGR. While \\\"Immediate\\\" delivery (Option B) lacks the nuance of steroid administration, it is the correct management *strategy* (delivery vs. expectant management). Option A is contraindicated. \\n\\nMinimal Fix: Change the stem findings to mild hypertension only (removing thrombocytopenia/liver issues) to make A correct, or change the key to B (and soften \\\"Immediate\\\" to \\\"Delivery after stabilization\\\").\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Miskeyed (K). Verdict: The keyed answer (A) is medically incorrect; Option B is the most defensible strategy, though imperfect. \n\nKey stem clues: 28 weeks gestation, history of APS, *new onset* thrombocytopenia, elevated liver enzymes, and fetal growth restriction (IUGR). \n\nMedical Reasoning: The triad of hemolysis (implied by dropping platelets/APS context), elevated liver enzymes, and low platelets (HELLP syndrome), or preeclampsia with severe features, is the most likely diagnosis. According to ACOG and international guidelines, thrombocytopenia and liver dysfunction are *severe features* of preeclampsia. The standard of care for HELLP/severe preeclampsia at 28 weeks is delivery (Option B), typically after a 48-hour course of corticosteroids for fetal lung maturity. \n\nLogical/Medical Issue: The provided rationale falsely claims the patient is \"without severe features,\" directly contradicting the clinical findings in the stem. Option A (continuation of pregnancy with just aspirin/heparin) is dangerous expectant management for a patient with HELLP/severe preeclampsia and IUGR. While \"Immediate\" delivery (Option B) lacks the nuance of steroid administration, it is the correct management *strategy* (delivery vs. expectant management). Option A is contraindicated. \n\nMinimal Fix: Change the stem findings to mild hypertension only (removing thrombocytopenia/liver issues) to make A correct, or change the key to B (and soften \"Immediate\" to \"Delivery after stabilization\").", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-010", "question": "In the critical care unit, a 60-year-old patient with acute respiratory distress syndrome on mechanical ventilation develops refractory hypoxemia despite prone positioning. Extracorporeal membrane oxygenation is considered. What is the primary indication for venovenous ECMO in this scenario?", "options": ["PaO2/FiO2 ratio less than 80 with FiO2 greater than 90%", "Hypercapnia unresponsive to increased minute ventilation", "Right ventricular failure on echocardiography", "Sepsis-induced myocardial depression", "Barotrauma from high plateau pressures"], "answer": "A", "answer_index": 0, "explanation": "Venovenous ECMO is indicated for severe ARDS when PaO2/FiO2 <80 on FiO2 >90%, despite optimal ventilatory support, to provide gas exchange. Hypercapnia alone may be managed with permissive strategies or ECCO2R. Right ventricular failure would prompt venoarterial ECMO consideration instead.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item is a standard, well-constructed board-style question regarding indications for venovenous (VV) ECMO in ARDS. The vignette describes a patient with refractory hypoxemia, and the question asks for the primary indication for VV-ECMO. Option A (PaO2/FiO2 < 80) accurately reflects the widely accepted physiological threshold for severe ARDS warranting ECMO consideration (e.g., EOLIA trial criteria). Options C (RV failure) and D (myocardial depression) describe conditions requiring hemodynamic support, which would necessitate Venoarterial (VA) ECMO, not VV-ECMO, allowing for clear discrimination. Option B (hypercapnia) is a potential indication for ECMO/ECCO2R, but given the stem specifically highlights 'refractory hypoxemia,' Option A is the objectively best answer. Option E is a rationale for lung rest but not the primary initiation criterion. The item is logically valid and medically accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item is a standard, well-constructed board-style question regarding indications for venovenous (VV) ECMO in ARDS. The vignette describes a patient with refractory hypoxemia, and the question asks for the primary indication for VV-ECMO. Option A (PaO2/FiO2 < 80) accurately reflects the widely accepted physiological threshold for severe ARDS warranting ECMO consideration (e.g., EOLIA trial criteria). Options C (RV failure) and D (myocardial depression) describe conditions requiring hemodynamic support, which would necessitate Venoarterial (VA) ECMO, not VV-ECMO, allowing for clear discrimination. Option B (hypercapnia) is a potential indication for ECMO/ECCO2R, but given the stem specifically highlights 'refractory hypoxemia,' Option A is the objectively best answer. Option E is a rationale for lung rest but not the primary initiation criterion. The item is logically valid and medically accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]